Logo ET_18_
Rome, Italy, October 11-14, 2023

Conference Program

Wednesday, October 11, 2023

17:00-18:00: Registration
18:00-20:00: Welcome Faculty Meeting


Thursday, October 12, 2023

8:50-9:00: Opening Remarks
Carmine Cardillo, Catholic University of the Sacred Heart, Rome, Italy
Neeraj Dhaun, University of Edimburgh, Edimburgh, UK
Francesca Schinzari, Policlinico Gemelli IRCCS, Rome, Italy

9:00-9:30
Opening Lecture:
Recent advances in drugs acting on the ET-1 system
Anthony Davenport, University of Cambridge, Cambridge, UK

9:30-11:10: Morning Session 1: ET-1 targeting in oncology
Chairs:
Pedro D’Orleans-Juste, Université de Sherbrooke, Sherbrooke, Canada
Janet Maguire, University of Cambridge, Cambridge, UK

9:30-10:00
KeyNote Lecture:
Role of the endothelin system in cancer-supporting phenotypic alterations
Rajkumar Savai, Liebig University, Giessen, Germany

10:00-10:15 Selected oral presentation
10:15-10:30 Selected oral presentation
10-30-10:45 Selected oral presentation

10:45-11:10 I
nvited Lecture:
I
dentification of new therapeutic vulnerabilities in cancer exploiting the molecular ET-averse
Anna Bagnato, Regina Elena National Cancer Institute, Rome, Italy

11:10-11:30 Coffee break

11:30-13:15
Morning Session 2: Endothelin antagonism in hypertension

Chairs:
David Webb, The Queen Medical’s Research Institute, Edinburgh, Scotland
Ivana Vaneckova, Czech Academy of Sciences, Prague, Czech Republic

11:30-12:00
KeyNote Lecture:
Non-selective ET receptor antagonism in resistant hypertension: the PRECISION trial
Ernesto Schiffrin, McGill University, Montreal, Canada

12:00-12:15 Selected oral presentation
12:15:12:30 Selected oral presentation
12:30:12:45 Selected oral presentation

12:45-13:15
Special Lecture
Nitric oxide
Louis J. Ignarro, UCLA, Nobel Prize in Physiology or Medicine 1998

13:15-14:00 Lunch

14:00-15:00
Poster Session 1
Chairs:
Jennifer Pollock, University of Alabama, Birmingham, USA
Michelle Gumz, University of Florida, Gainesville, USA

15:00-16:45
Afternoon Session 1: Endothelin-1 and neurological disorders
Chairs:
Rita Tostes, University of Sao Paulo, Sao Paulo, Brazil
Kelly Hyndman, University of Alabama at Birmingham, Birmingham, USA

15:00-15:30
KeyNote Lecture:
Effects of endothelin-1 on the brain microvasculature
Adviye Ergul, Medical University of South Carolina, Charleston, USA:

15:30-15:45 Selected oral presentation
15:45-16:00 Selected oral presentation
16:00-16:15 Selected oral presentation

16:15-16:45
Invited Lecture:
Advances in the treatment of neurologic disorders using drugs active on the endothelin system
Anil Gulati, Midwestern University of Illinois, Chicago, USA

Friday October 13, 2023
9:00-11:00:
Morning Session 3: Recent acquisitions in the treatment of kidney disease
Chairs:
Ariela Benigni, Mario Negri Institute, Bergamo, Italy
David Pollock, University of Alabama, Birmingham, USA

9:00-9:30
KeyNote Lecture:
Review of recent clinical trials with drugs targeting the ET-1 system
Hiddo Lambers Heerspink, University Medical Center, Groningen, The Netherlands

9:30-9:45 Selected oral presentation
9:45-10:00 Selected oral presentation
10:00-10:15 Selected oral presentation

10:15-10:45
Invited Lecture:
Is there a role of ET antagonism for nephroprotection in the era of SGLT2 or mineralcorticoid receptor inhibition?
Pierre-Louis Tharaux, Centre de Recherche Cardiovasculaire, Paris, France

10:45-11:05 Coffee break

11:20-13:15
Morning Session 4: Cardiology
Chairs:
John Pernow, Karolinska Institutet, Stockolm, Sweden
Rajat Gupta, Harvard Medical School, Boston, U.S.A.

11:05-11: 35 KeyNote Lecture:
Could targeting the endothelin system become a suitable approach in HFpEF?
Kieran Daugherty, University of Glasgow, Glasgow, Scotland

11:35-11:50 Selected oral presentation
11:50-12:05 Selected oral presentation
12:05-12:20 Selected oral presentation

12:20-12:55
Invited Lecture:
Endothelin in coronary artery diseases
Matthias Barton, University of Zurich, Zurich, Switzerland

12:55-13:15
Invited Lecture:
Mandibulofacial dysostosis with alopecia resulting from ETAR gain-of-function
Y. Kurihara, Unviersity of Tokyo, Tokyo, Japan

13:15-14:00 Lunch

14:00-15:00
Poster Session 2
Chairs:
Ivana Vaneckova, Czech Academy of Sciences, Prague, Czech Republic
Kelly Hyndman, University of Alabama, Birmingham, U.S.A.

15:00-16:45
Afternoon Session 2: Endocrinology and Metabolism
Chairs:
Manfredi Tesauro, Tor Vergata University, Rome, Italy
Jo De Mey, University of Maastricht, Maastricht, Netherlands

15:00-15:30
KeyNote Lecture:
Role of ET-1 in the oxidative stress associated with diabetic vasculopathy
Rhian Touyz, McGill University, Montreal, Canada

15:30-15:45 Selected oral presentation
15:45-16:00 Selected oral presentation
16:00-16:15 Selected oral presentation

16:15-16:45
Invited Lecture:
Role of endothelin and endothelin antagonism in non-alcoholic fatty liver degeneration (NALFD)
Wilhelmus Kwanten, University of Antwerp, Antwerp, Belgium

Saturday October 14, 2023


9:00-10:45:
Morning Session 5: Pulmonology and Rheumatology
Chairs:
Pedro D’Orleans-Juste University of Sherbrooke, Sherbrooke, Canada
Carmine Cardillo, Catholic University, Rome, Italy

9:00-9:30
KeyNote Lecture:
Update on the use of ET-1 antagonists in pulmonary hypertension
Noriaki Emoto. Kobe Pharmaceutical University, Kobe, Japan:

9:30-9:45 Selected oral presentation
9:45-10:00 Selected oral presentation
10:00-10:15 Selected oral presentation

10:15-10:45
Invited Lecture:
Role of ET-1 in vasculitis
Neeraj Dhaun, University of Edinburgh, Edinburgh, Scotland

10:45-11:05 Coffee Break

11:05-12:50
Morning Session 6: Dermatology and Women's Health
Chairs:
Matthias Barton, University of Zurich, Zurich, Switzerland
Donald Kohan University of Utah, Salt Lake City, USA

11:05-11:35
KeyNote Lecture:
ET-1 and hair follicle regeneration
Michael Rendl, Icahn School of Medicine at Mount Sinai, New York, USA

11:35-11:50 Selected oral presentation
11:50-12:05 Selected oral presentation
12:05-12:20 Selected oral presentation

12:20-12:50
Invited Lecture:
Role of ET-1 in pre-eclampsia
Jan Danser, Erasmus University, Rotterdam, The Netherlands:

12:50-13:35 Lunch

13:35-14:45
Round Table: Endothelin targeting: where are we going?
Donald Kohan, University of Utah, Salt Lake City, Utah, USA, Moderator and Chair
Introduction
Panelists: TBD

14:45-15:15
Award Ceremony

15:15-15:45
ET-18 Highlights
Masashi Yanagisawa, University of Tsukuba, Tsukuba, Japan

15:45-16:00 Closing remarks of the Conference Chairs